INDmoney
Crispr Therapeutics Ag Stock Performance
as on January 21, 2026 at 8:40 pm IST
Day's Low
Day's High
$51.90$53.58
2.83%
Downside
0.32%
Upside
52 Week's Low
52 Week's High
$30.04$78.4843.76%
Downside
46.94%
Upside
Crispr Therapeutics Ag share price movements today
- Previous Close
- $52.61
- Open
- $52.15
- Volume
- 148.6K
- Day's Low - High
- $51.90 - $53.58
- 52 Week Low - High
- $30.04 - $78.48
Crispr Therapeutics Ag Historical Returns
- 1 Month Return
- -5.82 %
- 3 Month Return
- -27.25 %
- 1 Year Return
- + 26.74 %
- 3 Year Return
- + 6.05 %
- 5 Year Return
- -71.58 %
Crispr Therapeutics Ag Stock Fundamentals & Key Indicators
Check Crispr Therapeutics Ag market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$5.1B
EPS (TTM)
-6.1945
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-15.21
Industry PE ratio
6.809270833333334
PEG Ratio
-0.2142
EBITDA
-459.5M
Revenue (TTM)
38.3M
Profit Margin
0.00%
Return On Equity TTM
-25.33%
Crispr Therapeutics Ag Stock Valuation
Track how Crispr Therapeutics Ag P/E has moved over time to understand its valuation trends.
Crispr Therapeutics Ag in the last 5 years
Lowest (-28.21x)
December 31, 2023
Today (-15.21x)
January 21, 2026
Industry (6.81x)
January 21, 2026
Highest (26.38x)
September 30, 2021
Today’s Price to Earnings Ratio: -15.21x
Crispr Therapeutics Ag vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Crispr Therapeutics Ag with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $5.1B | -71.58% | -15.21 | 0.00% | |
| BUY | $47.4B | 113.21% | 1237.91 | 1.36% | |
| BUY | $113.2B | 85.25% | 31.06 | 31.35% | |
| NA | $37.4B | NA | 663.12 | 1.38% | |
| BUY | $77.7B | 37.03% | 17.57 | 32.13% |
Stock Returns calculator for Crispr Therapeutics Ag Stock including INR - Dollar returns
The Crispr Therapeutics Ag stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Crispr Therapeutics Ag investment value today
Current value as on today
₹1,34,701
Returns
₹34,701
(+34.7%)
Returns from Crispr Therapeutics Ag Stock
₹28,668 (+28.67%)
Dollar Returns*
₹6,033 (+6.03%)
Analyst Recommendation on Crispr Therapeutics Ag Stock
Based on 35 analysts
54.29%
Buy
37.14%
Hold
8.57%
Sell
Based on 35 analysts, 54.29% of analysts recommend a 'BUY' rating for Crispr Therapeutics Ag. Average target price of $83.46
Crispr Therapeutics Ag Share Price Target
Get share price movements and forecasts by analysts on Crispr Therapeutics Ag.
What analysts predicted
36.01%UPSIDE
Target Price
$83.46
Current Price
$53.41
Analyzed by
35 Analysts
Target
$83.46
Crispr Therapeutics Ag target price $83.46, a slight upside of 36.01% compared to current price of $53.41. According to 35 analysts rating.
Crispr Therapeutics Ag Stock’s Investor Sentiment and Interest
Investment in Crispr Therapeutics Ag Shares on INDmoney has grown by 6.83% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:6.83% versus previous 30 day period
Search interest for Crispr Therapeutics Ag Stock has increased by 67% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:67% versus previous 30 day period
Crispr Therapeutics Ag Quarterly Profit & Loss
All numbers in Millions USD
Crispr Therapeutics Ag Annual Profit & Loss
All numbers in Millions USD
Crispr Therapeutics Ag Quarterly Cash Flow
All numbers in Millions USD
Crispr Therapeutics Ag Annual Cash Flow
All numbers in Millions USD
Insights on Crispr Therapeutics Ag
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 2 quarters, -208.54M → -106.44M (in $), with an average increase of 95.9% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 25.5% return, outperforming this stock by 19.5%
- NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 52.8% return, outperforming this stock by 26.1%
NEGATIVE IMPACTPrice Dip
In the last 7 days, CRSP stock has moved down by -7.5%
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 892.0K → 889.0K (in $), with an average decrease of 0.3% per quarter
About Crispr Therapeutics Ag
| Organisation | Crispr Therapeutics Ag |
| Headquarters | Baarerstrasse 14, Zug, Switzerland, 6300 |
| Industry | Health Technology |
| CEO | Dr. Samarth Kulkarni Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Crispr Therapeutics Ag
Name | Title |
|---|---|
Dr. Emmanuelle Marie Charpentier Ph.D. | Co-Founder & Scientific Advisory Board Member |
Dr. Matthew Porteus M.D., Ph.D. | Scientific Founder & Advisory Board Member |
Dr. Daniel G. Anderson Ph.D. | Scientific Founder & Advisory Board Member |
Mr. James R. Kasinger J.D. | General Counsel & Secretary |
Dr. Raju Yashaswi Prasad Ph.D. | Chief Financial Officer |
Dr. Naimish Patel C.M., M.D. | Chief Medical Officer |
Mr. Shaun Foy CFA | Co-Founder |
Dr. Craig C. Mello Ph.D. | Scientific Founder & Advisory Board Member |
Dr. Chad A. Cowan Ph.D. | Scientific Founder |
Dr. Samarth Kulkarni Ph.D. | CEO & Chairman |
FAQs
What is Crispr Therapeutics Ag share price today?
Crispr Therapeutics Ag share price today is $53.41 as on . Crispr Therapeutics Ag share today touched a day high of $53.58 and a low of $51.9.
What is the 52 week high and 52 week low for Crispr Therapeutics Ag share?
Crispr Therapeutics Ag share touched a 52 week high of $78.48 on and a 52 week low of $30.04 on . Crispr Therapeutics Ag stock price today i.e. is trending at $53.41,which is 31.94% down from its 52 week high and 77.80% up from its 52 week low.
What is Crispr Therapeutics Ag's market capitalisation today?
Crispr Therapeutics Ag market capitalisation is $0.01T as on .
How to invest in Crispr Therapeutics Ag Stock (CRSP) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Crispr Therapeutics Ag on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Crispr Therapeutics Ag Shares that will get you 0.0281 shares as per Crispr Therapeutics Ag share price of $53.41 per share as on January 21, 2026 at 8:40 pm IST.
What is the minimum amount required to buy Crispr Therapeutics Ag Stock (CRSP) from India?
Indian investors can start investing in Crispr Therapeutics Ag (CRSP) shares with as little as ₹91.673 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹916.73 in Crispr Therapeutics Ag stock (as per the Rupee-Dollar exchange rate as on ).
Based on Crispr Therapeutics Ag share’s latest price of $53.41 as on January 21, 2026 at 8:40 pm IST, you will get 0.1872 shares of Crispr Therapeutics Ag. Learn more about
fractional shares .
What are the returns that Crispr Therapeutics Ag has given to Indian investors in the last 5 years?
Crispr Therapeutics Ag stock has given -71.58% share price returns and 24.57% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?